» Articles » PMID: 33007412

The Role of Structure and Function Changes of Sensory Nervous System in Intervertebral Disc-related Low Back Pain

Overview
Date 2020 Oct 2
PMID 33007412
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Low back pain (LBP) is a common musculoskeletal symptom, which can be developed in multiple clinical diseases. It is widely recognized that intervertebral disc (IVD) degeneration (IVDD) is one of the leading causes of LBP. However, the pathogenesis of IVD-related LBP is still controversial, and the treatment means are also insufficient to date. In recent decades, the role of structure and function changes of sensory nervous system in the induction and the maintenance of LBP is drawing more and more attention. With the progress of IVDD, IVD cell exhaustion and extracellular matrix degradation result in IVD structural damage, while neovascularization, innervation and inflammatory activation further deteriorate the microenvironment of IVD. New nerve ingrowth into degenerated IVD amplifies the impacts of IVD-derived nociceptive molecules on sensory endings. Moreover, IVDD is usually accompanied with disc herniation, which could injure and inflame affected nerves. Under mechanical and pro-inflammatory stimulation, the pain-transmitting pathway exhibits a sensitized function state and ultimately leads to LBP. Hence, relevant pathogenic factors, such as neurotrophins, ion channels, inflammatory factors, etc., are supposed to serve as promising therapeutic targets for LBP. The purpose of this review is to comprehensively summarize the current evidence on 1) the pathological changes of sensory nervous system during IVDD and their association with LBP, and 2) potential therapeutic strategies for LBP targeting relevant pathogenic factors.

Citing Articles

NOX4 Regulates NLRP3 by Inhibiting the Ubiquitination of LRRC8A to Promote Ferroptosis in Nucleus Pulposus Cells.

Zhang F, Cui D, Wang Z, Li Y, Wang K, Lu H Inflammation. 2025; .

PMID: 39909992 DOI: 10.1007/s10753-025-02253-0.


Role of neurogenic inflammation in intervertebral disc degeneration.

Peng B, Li Y, Yang L World J Orthop. 2025; 16(1):102120.

PMID: 39850033 PMC: 11752484. DOI: 10.5312/wjo.v16.i1.102120.


Developments and clinical experiences in collagenase chemonucleolysis for lumbar disc herniation: a narrative review.

Zhang H, Zhang C, Li L, Hu M, Zhao J, Zheng Z Front Med (Lausanne). 2025; 11():1522568.

PMID: 39845813 PMC: 11750870. DOI: 10.3389/fmed.2024.1522568.


Fibrocyte enrichment and myofibroblastic adaptation causes nucleus pulposus fibrosis and associates with disc degeneration severity.

Sun Y, Peng Y, Su Z, So K, Lu Q, Lyu M Bone Res. 2025; 13(1):10.

PMID: 39828732 PMC: 11743603. DOI: 10.1038/s41413-024-00372-2.


Discovery of Glucose Metabolism-Associated Genes in Neuropathic Pain: Insights from Bioinformatics.

Yu Y, Cheung Y, Cheung C Int J Mol Sci. 2025; 25(24.

PMID: 39769264 PMC: 11679926. DOI: 10.3390/ijms252413503.